Treatment of COVID-19 with convalescent plasma: lessons from past coronavirus outbreaks.

In addition, while findings did not reach statistical significance, the trend for a modest improvement in mortality (24% versus 16%) is useful for informing power calculations in upcoming randomized control trials [ 46 ].

also in 111,027 other papers